B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Rilmenidine

300 PubMed studies analyzed · 24 RCTs · Evidence Score: 46.7

Research Domains

Rilmenidine has been studied across 19 research domains including ❤️ Cardiovascular, 🫘 Kidney, 🧠 Focus & Attention, 🔥 Metabolic, ⏳ Longevity & Aging. The primary research focus is ❤️ Cardiovascular with 57% of studies addressing this area.

Loading evidence profile...

This evidence profile for Rilmenidine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.